AGIOS PHARMACEUTICALS ($AGIO) posted quarterly earnings results on Thursday, May 1st. The company reported earnings of -$1.55 per share, beating estimates of -$1.82 by $0.27. The company also reported revenue of $8,730,000, missing estimates of $9,832,942 by $-1,102,942.
You can see Quiver Quantitative's $AGIO stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
AGIOS PHARMACEUTICALS Insider Trading Activity
AGIOS PHARMACEUTICALS insiders have traded $AGIO stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $AGIO stock by insiders over the last 6 months:
- JAMES WILLIAM BURNS (Chief Legal Officer) has made 0 purchases and 2 sales selling 21,752 shares for an estimated $1,135,774.
- RAHUL D. BALLAL has made 0 purchases and 5 sales selling 20,000 shares for an estimated $1,117,146.
- BRIAN GOFF (Chief Executive Officer) has made 0 purchases and 2 sales selling 12,947 shares for an estimated $460,136.
- JACQUALYN A FOUSE sold 7,497 shares for an estimated $194,172
- TSVETA MILANOVA (Chief Commercial Officer) has made 0 purchases and 2 sales selling 4,485 shares for an estimated $149,975.
- SARAH GHEUENS (Chief Medical Officer) has made 0 purchases and 3 sales selling 4,005 shares for an estimated $142,337.
- THEODORE JAMES JR. WASHBURN (Principal Accounting Officer) sold 2,272 shares for an estimated $78,134
- DAVID SCADDEN sold 200 shares for an estimated $9,256
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AGIOS PHARMACEUTICALS Hedge Fund Activity
We have seen 111 institutional investors add shares of AGIOS PHARMACEUTICALS stock to their portfolio, and 106 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JEFFERIES FINANCIAL GROUP INC. added 1,500,000 shares (+inf%) to their portfolio in Q4 2024, for an estimated $49,290,000
- CITADEL ADVISORS LLC added 1,421,940 shares (+12116.1%) to their portfolio in Q4 2024, for an estimated $46,724,948
- VESTAL POINT CAPITAL, LP removed 760,000 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $24,973,600
- JPMORGAN CHASE & CO removed 697,630 shares (-40.7%) from their portfolio in Q4 2024, for an estimated $22,924,121
- MARSHALL WACE, LLP removed 631,657 shares (-50.0%) from their portfolio in Q4 2024, for an estimated $20,756,249
- PRICE T ROWE ASSOCIATES INC /MD/ removed 408,975 shares (-14.4%) from their portfolio in Q4 2024, for an estimated $13,438,918
- POLAR CAPITAL HOLDINGS PLC removed 375,000 shares (-37.4%) from their portfolio in Q4 2024, for an estimated $12,322,500
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
AGIOS PHARMACEUTICALS Congressional Stock Trading
Members of Congress have traded $AGIO stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $AGIO stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 01/29.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
